Christi Blakkolb, MD
Plastic and Reconstructive Surgery · Houston, TXNPI 1558689463
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,539 of the $68,925 with a category attached, or 96.5%. AbbVie accounts for 97.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $66,760 and has fallen 99.5% since, to $363 in 2025. Among plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $1641.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$67K
- Merz North America, Inc.$1K
- Kls-martin L.p.$179
- Davol Inc.$159
- Kerecis Limited$126
- Smith+Nephew$74
- plus $349 from 10 others
What the payments were for
- Speaking & faculty fees$66,53997%
- Food & beverage$2,3723%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $67,007 |
| Merz North America, Inc. | 10 | $1,031 |
| Kls-martin L.p. | 1 | $179 |
| Davol Inc. | 1 | $159 |
| Kerecis Limited | 1 | $126 |
| Smith+Nephew | 1 | $74 |
| Sientra, Inc. | 1 | $71 |
| Avita Medical Americas, LLC | 2 | $68 |
| KCI USA, Inc. | 2 | $55 |
| Axogen | 1 | $35 |
| Mentor Worldwide LLC | 1 | $28 |
| Shire North American Group Inc | 1 | $23 |
| Molnlycke Health Care US, LLC | 1 | $22 |
| Pfizer | 1 | $19 |
| Johnson & Johnson | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$68,925 in reported general payments places this provider in the 95th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Houston
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Justin BroylesHouston$48K
- Pablo PadillaHouston$46K
- Courtney El-ZokmHouston$29K
- John NguyenHouston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.